Minocycline provides protection against beta-amyloid(25-35)-induced alterations of the somatostatin signaling pathway in the rat temporal cortex.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience

• Publication date

  2008-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuroscience.2008.04.036PMID 18555616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatostatin and Alzheimer's disease.

  2008cited by this paper
• Enhanced ERK dependent CREB activation reduces apoptosis in staurosporine-treated human neuroblastoma SK-N-BE(2)C cells.

  2006cited by this paper
• Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia.

  2006cited by this paper
• Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice

  2006influential reference
• Minocycline exerts inhibitory effects on multiple mitogen‐activated protein kinases and IκBα degradation in a stimulus‐specific manner in microglia

  2006cited by this paper
• FFECTS OF SINGLE AND CONTINUOUS ADMINISTRATION OF MYLOID-PEPTIDE ( 25 – 35 ) ON ADENYLYL CYCLASE ACTIVITY ND THE SOMATOSTATINERGIC SYSTEM IN THE RAT FRONTAL

  2005cited by this paper
• Effects of single and continuous administration of amyloid beta-peptide (25-35) on adenylyl cyclase activity and the somatostatinergic system in the rat frontal and parietal cortex.

  2005cited by this paper
• Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.

  2005cited by this paper
• Minocycline in phenotypic models of Huntington's disease.

  2005cited by this paper
• Protective effects of insulin‐like growth factor‐I on the somatostatinergic system in the temporal cortex of β‐amyloid‐treated rats

  2005cited by this paper
• Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

  2005cited by this paper
• Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early β-Amyloid Accumulation

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Differential β-Arrestin Trafficking and Endosomal Sorting of Somatostatin Receptor Subtypes*

  2004cited by this paper
• Desensitization of G protein-coupled receptors and neuronal functions.

  2004cited by this paper
• Minocycline protects basal forebrain cholinergic neurons from mu p75‐saporin immunotoxic lesioning

  2004cited by this paper
• Minocycline inhibits neuronal death and glial activation induced by β‐amyloid peptide in rat hippocampus

  2004cited by this paper
• Minocycline prevents glutamate‐induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways

  2004cited by this paper
• In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.

  2002cited by this paper
• In vivo conversion of racemized β‐amyloid ([D‐Ser26]Aβ1–40) to truncated and toxic fragments ([D‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

  2002cited by this paper
• Transcriptional regulation by the phosphorylation-dependent factor CREB

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised*

  2001cited by this paper
• Characterization of 5'-flanking region of rat somatostatin receptor sst2 gene: transcriptional regulatory elements and activation by Pitx1 and estrogen.

  2001cited by this paper
• Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis.

  2000cited by this paper
• Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells.

  2000cited by this paper
• Gene structure and regulation of the somatostatin receptor type 2.

  2000cited by this paper
• A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.

  1999cited by this paper
• Somatostatin and its receptor family.

  1999cited by this paper
• Regional Neuropeptide Pathology in Alzheimer's Disease: Corticotropin-Releasing Factor and Somatostatin

  1998cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Correlations between Water Maze Performance and Cortical Somatostatin mRNA and High‐affinity Binding Sites During Ageing in Rats

  1996cited by this paper
• Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice.

  1996cited by this paper
• Classification and nomenclature of somatostatin receptors.

  1995cited by this paper
• Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.

  1994cited by this paper
• β-Amyloid protein-induced Alzheimer's disease animal model

  1994influential reference
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Effects of minocycline on accumulation of cyclic AMP in cerebral cortex of rat. A comparison with lithium.

  1993cited by this paper
• SOMATOSTATIN: A NEUROPEPTIDE SYSTEM PATHOLOGICALLY ALTERED IN ALZHEIMER'S DISEASE AND DEPRESSION

  1992cited by this paper
• Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease.

  1992cited by this paper
• Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease

  1986cited by this paper
• Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.

  1985cited by this paper
• Somatostatin receptor binding in rat cerebral cortex. Characterization using a nonreducible somatostatin analog.

  1983cited by this paper
• High affinity binding sites for a somatostatin-28 analog in rat brain.

  1981cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Pharmacotherapeutics of the newer tetracyclines.

  1980influential reference
• Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

  1980cited by this paper
• The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.

  1976cited by this paper
• A protein binding assay for adenosine 3':5'-cyclic monophosphate.

  1970cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963influential reference
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types

  2023cites this paper
• Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types

  2023cites this paper
• Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD)

  2023cites this paper
• Effects of Minocycline on Cognitive Impairment, Hippocampal Inflammatory Response, and Hippocampal Alzheimer's Related Proteins in Aged Rats after Propofol Anesthesia

  2022cites this paper
• Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation

  2022influential citation
• The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia

  2020cites this paper
• Combinatory FK506 and Minocycline Treatment Alleviates Prion-Induced Neurodegenerative Events via Caspase-Mediated MAPK-NRF2 Pathway

  2019cites this paper
• Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease

  2019cites this paper
• Effect of pretreatment with intracerebroventricular injection of minocycline on morphine‐induced memory impairment in passive avoidance test: Role of P‐CREB and c‐Fos expression in the dorsal hippocampus and basolateral amygdala regions

  2019cites this paper
• Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract

  2018cites this paper
• Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters

  2017cites this paper
• Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer’s Disease via Enhancing Neuron Differentiation and Paracrine Action

  2015cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Normal cognition in transgenic BRI2-Aβ mice

  2013cites this paper
• Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1–42-infused mouse model of Alzheimer's disease

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• Aquaporin-4 Inhibition Mediates Piroxicam-Induced Neuroprotection against Focal Cerebral Ischemia/Reperfusion Injury in Rodents

  2013cites this paper
• Oligomers of β-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1β, tumour necrosis factor-α, and a nuclear factor κ-B mechanism in the rat brain.

  2012cites this paper
• Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia

  2012cites this paper
• Cognitive effects of NSAIDs in cerebral ischemia: a hypothesis exploring mechanical action mediated pharmacotherapy.

  2012cites this paper
• Combination therapy of ifenprodil with piroxicam may be an effective therapeutic intervention in cerebral stroke: a hypothesis.

  2012cites this paper
• Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: Roles of Bcl-2 and thioredoxin.

  2011cites this paper
• Minocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemia.

  2011cites this paper
• Tissue dependent differences in G-protein coupled receptor kinases associated with 5-HT4 receptor desensitization in the rat gastro-intestinal tract.

  2011cites this paper
• Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus

  2011cites this paper
• Behavioural and cellular effects of exogenous amyloid-β peptides in rodents.

  2011cites this paper
• Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.

  2010cites this paper
• Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice.

  2010cites this paper
• Diabetes mellitus: channeling care through cellular discovery.

  2010cites this paper
• Oxidative stress: Biomarkers and novel therapeutic pathways

  2010cites this paper
• Novel Strategies for Neurovascular Longevity During Aging

  2010cites this paper
• Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.

  2010cites this paper
• New strategies for Alzheimer disease and cognitive impairment

  2009cites this paper
• Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology

  2009cites this paper
• Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease.

  2009cites this paper
• The Vitamin Nicotinamide: Translating Nutrition into Clinical Care

  2009cites this paper
• Tetracycline and its Analogues as Drugs Against Protein Aggregation and Amyloid Formation

  2009cites this paper
• Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH‐SY5Y neuroblastoma cells

  2009cites this paper
• Minocycline and neurodegenerative diseases.

  2009cites this paper
• Selective apoptosis induction in the hippocampal mossy fiber pathway by exposure to CT105, the C-terminal fragment of Alzheimer's amyloid precursor protein.

  2009cites this paper